Compared with CD5- DLBCL, the CD5+ group revealed female preponderance (p = 0.002), more than one extranodal site involvement (p = 0.002), and frequent bone marrow involvement (p = 0.01). This evidence concerns the gene CD5 and diffuse large B-cell lymphoma.